W. Fridman

发表

L. Zitvogel, L. Galluzzi, G. Kroemer, 2012, Oncoimmunology.

L. Zitvogel, L. Galluzzi, G. Kroemer, 2012, Oncoimmunology.

Fce Receptor I-Associatedlyn-Dependent Phosphorylation of Fcg Receptor IIB During Negative Regulation of Mast Cell Activation

J. Cambier, O. Malbec, Marc, 1998 .

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study

N. Rioux-Leclercq, C. Sautès-Fridman, A. Desnoyer, 2022, Journal for ImmunoTherapy of Cancer.

Dynamic interactions of Fc γ RIIB with filamin-bound SHIP1 amplify F-actin-dependent negative regulation of Fc ε RI signaling

M. Daëron, Renaud Lesourne, W. Fridman, 2008 .

In vivo induction of functional FcγRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G‐CSF (rMetHuG‐CSF)

E. Tartour, S. Moutel, J. Teillaud, 1998, British journal of haematology.

Trial Watch-Oncolytic viruses and cancer therapy.

L. Zitvogel, L. Galluzzi, G. Kroemer, 2016 .

Soluble interleukin‐2 receptor and metalloproteinase‐9 expression in head and neck cancer: prognostic value and analysis of their relationships

E. Tartour, W. Fridman, D. Brasnu, 2007, Clinical and experimental immunology.

Positive and Negative Signaling in Mast Cells Linker for Activation of T Cells Integrates

B. Malissen, M. Malissen, M. Daëron, 2004 .

Better understanding tumor–host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies

E. Tartour, D. Brasnu, P. Bruneval, 2010, Head & neck.

The essential role of the in situ immune reaction in human colorectal cancer

J. Galon, F. Pagès, W. Fridman, 2008, Journal of leukocyte biology.

Soluble FCγ receptors

E. Tartour, J. Galon, W. Fridman, 1993, Journal of leukocyte biology.

Recombinant Vaccinia Virus Encoding Human MUC1 and IL2 as Immunotherapy in Patients With Breast Cancer

A. Vincent-Salomon, M. Kieny, E. Tartour, 2000, Journal of immunotherapy.

LPS induces rapid IL‐10 release by M‐CSF‐conditioned tolerogenic dendritic cell precursors

C. Boix, W. Kwan, W. Fridman, 2007, Journal of leukocyte biology.

Characterization of the mononuclear cell infiltrate in human malignant melanoma

H. Peter, J. Césarini, J. Cesarini, 1975, International journal of cancer.

Oncolytic viruses for cancer therapy

L. Zitvogel, L. Galluzzi, G. Kroemer, 2014 .

Phase I trial with recombinant interleukin‐2 (rIL‐2): immune activation by rIL‐2 alone or following pretreatment with recombinant interferon‐gamma

W. Fridman, T. Tursz, C. Mathiot, 1990, Clinical and experimental immunology.

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling

S. Chevret, W. Fridman, E. Becht, 2018, Leukemia.

Increased levels of soluble low‐affinity Feγ receptors (IgG‐binding factors) in the sera of tumour‐bearing mice

E. Tartour, A. Lynch, J. Teillaud, 1992 .

Presence of in vivo‐activated t‐cells expressing hla‐dr molecules and il‐2 receptors in peripheral blood of patients with nasopharyngeal carcinoma

R. Ellouz, H. Kammoun, R. Kastally, 1987, International journal of cancer.

1451MO In-situ immune markers predict nivolumab (N) +/-ipilimumab (I) efficacy in frontline metastatic clear cell renal cell carcinoma (mccRCC): Key ancillary analyses from the BIONIKK randomized trial

C. Tournigand, C. Sautès-Fridman, S. Oudard, 2022, Annals of Oncology.

Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis

W. Fridman, T. Tursz, A. Tsapis, 1977, Nature.

Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

J. Banchereau, E. Tartour, C. Sautès-Fridman, 1999, Cancer research.

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

E. Tartour, W. Fridman, S. Oudard, 2011, Cancer and Metastasis Reviews.

Local immunostimulation induced by intravesical administration of autologous interferon‐gamma‐activated macrophages in patients with superficial bladder cancer

J. Lemonne, W. Fridman, J. Abastado, 2002, Clinical and experimental immunology.

Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA- linked control at the effector level

M. Lipinski, W. Fridman, T. Tursz, 1979, The Journal of experimental medicine.

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

J. Machiels, E. Tartour, W. Fridman, 2011, Cancer Immunology, Immunotherapy.

Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.

E. Tartour, W. Fridman, P. Kourilsky, 1994, Cancer research.

Synthetic and natural non-live vectors: rationale for their clinical development in cancer vaccine protocols.

E. Tartour, W. Fridman, N. Haicheur, 2002, Vaccine.

Complement Mutation‐Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation

W. Fridman, E. Thervet, C. Legendre, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.

O. Cochet, W. Fridman, B. Tocqué, 1998, Cancer research.

Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas.

E. Tartour, W. Fridman, X. Sastre-Garau, 1998, Journal of the National Cancer Institute.

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

E. Tartour, W. Fridman, C. Mathiot, 1994, British Journal of Cancer.

Anti-cytokines: promising tools for diagnosis and immunotherapy.

E. Tartour, W. Fridman, R. Lee, 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Anti-CD20 therapy induces a memory Th1 response through the IFN-γ/IL-12 axis and prevents protumor regulatory T-cell expansion in mice

W. Fridman, A. Metidji, C. Deligne, 2014, Leukemia.

Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages.

E. Tartour, W. Fridman, M. Rosenzwajg, 1996, Blood.

Complement Mutation‐Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation

E. Thervet, N. Kamar, V. Frémeaux-Bacchi, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Serum soluble interleukin–2 receptor concentrations as an independent prognostic marker in head and neck cancer

E. Tartour, V. Mosseri, F. Brunin, 2001, The Lancet.